Health · 1 sources covering this

STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·3h ago
STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/03c3be1f78b8ec9a7ac9322f0e4f1d6ee503136f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts"></iframe>

STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

How 1 sources are covering this

STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

More from Health

Some people with meat allergies from alpha-gal syndrome turn to exotic alternatives

The Ebola outbreak is breaking records -- and just marked a grim milestone

STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down

STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

Reader

Trust & legal

Across the network